Vioxx Withdrawal And Drug Safety: FDA To Join Audio Conference Nov. 10
This article was originally published in The Tan Sheet
Executive Summary
FDA Office of New Drugs Acting Director Sandra Kweder, MD, will discuss the impact of the Vioxx recall on drug safety regulation during an interactive Drug & Device Dialogue audio conference Nov. 10